Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.
Zhu GQ, Wang Y, Wang B, Liu WR, Dong SS, Chen EB, Cai JL, Wan JL, Du JX, Song LN, Chen SP, Yu L, Zhou ZJ, Wang Z, Zhou J, Shi YH, Fan J, Dai Z.
Zhu GQ, et al. Among authors: chen eb.
Cell Mol Gastroenterol Hepatol. 2022;13(5):1413-1447. doi: 10.1016/j.jcmgh.2022.02.006. Epub 2022 Feb 12.
Cell Mol Gastroenterol Hepatol. 2022.
PMID: 35158098
Free PMC article.